ID   RNF8_HUMAN              Reviewed;         485 AA.
AC   O76064; A6NN24; A8MYC0; B4DPG0; Q53H16; Q5NKW5;
DT   06-JUN-2002, integrated into UniProtKB/Swiss-Prot.
DT   01-NOV-1998, sequence version 1.
DT   10-MAY-2017, entry version 170.
DE   RecName: Full=E3 ubiquitin-protein ligase RNF8 {ECO:0000255|HAMAP-Rule:MF_03067};
DE            Short=hRNF8;
DE            EC=2.3.2.27 {ECO:0000255|HAMAP-Rule:MF_03067};
DE   AltName: Full=RING finger protein 8 {ECO:0000255|HAMAP-Rule:MF_03067};
DE   AltName: Full=RING-type E3 ubiquitin transferase RNF8;
GN   Name=RNF8 {ECO:0000255|HAMAP-Rule:MF_03067}; Synonyms=KIAA0646;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [GENOMIC DNA / MRNA] (ISOFORM 1), AND TISSUE
RP   SPECIFICITY.
RC   TISSUE=Brain;
RX   PubMed=9852682; DOI=10.1007/s100380050088;
RA   Seki N., Hattori A., Sugano S., Suzuki Y., Nakagawara A., Ohhira M.,
RA   Muramatsu M., Hori T., Saito T.;
RT   "Isolation, tissue expression, and chromosomal assignment of a novel
RT   human gene which encodes a protein with RING finger motif.";
RL   J. Hum. Genet. 43:272-274(1998).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), SUBCELLULAR LOCATION, TISSUE
RP   SPECIFICITY, INTERACTION WITH UBE2E2 AND UBE2N, AUTOUBIQUITINATION,
RP   AND MUTAGENESIS OF CYS-403.
RC   TISSUE=Fetal brain;
RX   PubMed=16215985; DOI=10.1002/jcb.20587;
RA   Plans V., Scheper J., Soler M., Loukili N., Okano Y., Thomson T.M.;
RT   "The RING finger protein RNF8 recruits UBC13 for lysine 63-based self
RT   polyubiquitylation.";
RL   J. Cell. Biochem. 97:572-582(2006).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Brain;
RX   PubMed=9734811; DOI=10.1093/dnares/5.3.169;
RA   Ishikawa K., Nagase T., Suyama M., Miyajima N., Tanaka A., Kotani H.,
RA   Nomura N., Ohara O.;
RT   "Prediction of the coding sequences of unidentified human genes. X.
RT   The complete sequences of 100 new cDNA clones from brain which can
RT   code for large proteins in vitro.";
RL   DNA Res. 5:169-176(1998).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RC   TISSUE=Kidney;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RA   Kalnine N., Chen X., Rolfs A., Halleck A., Hines L., Eisenstein S.,
RA   Koundinya M., Raphael J., Moreira D., Kelley T., LaBaer J., Lin Y.,
RA   Phelan M., Farmer A.;
RT   "Cloning of human full-length CDSs in BD Creator(TM) system donor
RT   vector.";
RL   Submitted (MAY-2003) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Hepatoma;
RA   Suzuki Y., Sugano S., Totoki Y., Toyoda A., Takeda T., Sakaki Y.,
RA   Tanaka A., Yokoyama S.;
RL   Submitted (APR-2005) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=14574404; DOI=10.1038/nature02055;
RA   Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L.,
RA   Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E.,
RA   Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R.,
RA   Almeida J.P., Ambrose K.D., Andrews T.D., Ashwell R.I.S.,
RA   Babbage A.K., Bagguley C.L., Bailey J., Banerjee R., Barker D.J.,
RA   Barlow K.F., Bates K., Beare D.M., Beasley H., Beasley O., Bird C.P.,
RA   Blakey S.E., Bray-Allen S., Brook J., Brown A.J., Brown J.Y.,
RA   Burford D.C., Burrill W., Burton J., Carder C., Carter N.P.,
RA   Chapman J.C., Clark S.Y., Clark G., Clee C.M., Clegg S., Cobley V.,
RA   Collier R.E., Collins J.E., Colman L.K., Corby N.R., Coville G.J.,
RA   Culley K.M., Dhami P., Davies J., Dunn M., Earthrowl M.E.,
RA   Ellington A.E., Evans K.A., Faulkner L., Francis M.D., Frankish A.,
RA   Frankland J., French L., Garner P., Garnett J., Ghori M.J.,
RA   Gilby L.M., Gillson C.J., Glithero R.J., Grafham D.V., Grant M.,
RA   Gribble S., Griffiths C., Griffiths M.N.D., Hall R., Halls K.S.,
RA   Hammond S., Harley J.L., Hart E.A., Heath P.D., Heathcott R.,
RA   Holmes S.J., Howden P.J., Howe K.L., Howell G.R., Huckle E.,
RA   Humphray S.J., Humphries M.D., Hunt A.R., Johnson C.M., Joy A.A.,
RA   Kay M., Keenan S.J., Kimberley A.M., King A., Laird G.K., Langford C.,
RA   Lawlor S., Leongamornlert D.A., Leversha M., Lloyd C.R., Lloyd D.M.,
RA   Loveland J.E., Lovell J., Martin S., Mashreghi-Mohammadi M.,
RA   Maslen G.L., Matthews L., McCann O.T., McLaren S.J., McLay K.,
RA   McMurray A., Moore M.J.F., Mullikin J.C., Niblett D., Nickerson T.,
RA   Novik K.L., Oliver K., Overton-Larty E.K., Parker A., Patel R.,
RA   Pearce A.V., Peck A.I., Phillimore B.J.C.T., Phillips S., Plumb R.W.,
RA   Porter K.M., Ramsey Y., Ranby S.A., Rice C.M., Ross M.T., Searle S.M.,
RA   Sehra H.K., Sheridan E., Skuce C.D., Smith S., Smith M., Spraggon L.,
RA   Squares S.L., Steward C.A., Sycamore N., Tamlyn-Hall G., Tester J.,
RA   Theaker A.J., Thomas D.W., Thorpe A., Tracey A., Tromans A., Tubby B.,
RA   Wall M., Wallis J.M., West A.P., White S.S., Whitehead S.L.,
RA   Whittaker H., Wild A., Willey D.J., Wilmer T.E., Wood J.M., Wray P.W.,
RA   Wyatt J.C., Young L., Younger R.M., Bentley D.R., Coulson A.,
RA   Durbin R.M., Hubbard T., Sulston J.E., Dunham I., Rogers J., Beck S.;
RT   "The DNA sequence and analysis of human chromosome 6.";
RL   Nature 425:805-811(2003).
RN   [8]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RA   Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L.,
RA   Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R.,
RA   Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V.,
RA   Hannenhalli S., Turner R., Yooseph S., Lu F., Nusskern D.R.,
RA   Shue B.C., Zheng X.H., Zhong F., Delcher A.L., Huson D.H.,
RA   Kravitz S.A., Mouchard L., Reinert K., Remington K.A., Clark A.G.,
RA   Waterman M.S., Eichler E.E., Adams M.D., Hunkapiller M.W., Myers E.W.,
RA   Venter J.C.;
RL   Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases.
RN   [9]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 1).
RC   TISSUE=Muscle;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [10]
RP   PROTEIN SEQUENCE OF 81-89; 156-173 AND 215-226, FUNCTION, SUBCELLULAR
RP   LOCATION, MASS SPECTROMETRY, AND MUTAGENESIS OF ARG-42.
RX   PubMed=23233665; DOI=10.1074/jbc.M112.423392;
RA   Zhang S., Zhou Y., Sarkeshik A., Yates J.R. III, Thomson T.M.,
RA   Zhang Z., Lee E.Y., Lee M.Y.;
RT   "Identification of RNF8 as a ubiquitin ligase involved in targeting
RT   the p12 subunit of DNA polymerase delta for degradation in response to
RT   DNA damage.";
RL   J. Biol. Chem. 288:2941-2950(2013).
RN   [11]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH UBE2E1; UBE2E2 AND
RP   UBE2E3, AND MUTAGENESIS OF CYS-403.
RX   PubMed=11322894; DOI=10.1046/j.1432-1327.2001.02169.x;
RA   Ito K., Adachi S., Iwakami R., Yasuda H., Muto Y., Seki N., Okano Y.;
RT   "N-terminally extended human ubiquitin-conjugating enzymes (E2s)
RT   mediate the ubiquitination of RING-finger proteins, ARA54 and RNF8.";
RL   Eur. J. Biochem. 268:2725-2732(2001).
RN   [12]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH RXRA, AND MUTAGENESIS
RP   OF CYS-403.
RX   PubMed=14981089; DOI=10.1074/jbc.M309148200;
RA   Takano Y., Adachi S., Okuno M., Muto Y., Yoshioka T.,
RA   Matsushima-Nishiwaki R., Tsurumi H., Ito K., Friedman S.L.,
RA   Moriwaki H., Kojima S., Okano Y.;
RT   "The RING finger protein, RNF8, interacts with retinoid X receptor
RT   alpha and enhances its transcription-stimulating activity.";
RL   J. Biol. Chem. 279:18926-18934(2004).
RN   [13]
RP   FUNCTION, CATALYTIC ACTIVITY, SUBCELLULAR LOCATION, INTERACTION WITH
RP   MDC1, DOMAIN, AND MUTAGENESIS OF ARG-42 AND CYS-403.
RX   PubMed=18001824; DOI=10.1016/j.cell.2007.09.040;
RA   Mailand N., Bekker-Jensen S., Faustrup H., Melander F., Bartek J.,
RA   Lukas C., Lukas J.;
RT   "RNF8 ubiquitylates histones at DNA double-strand breaks and promotes
RT   assembly of repair proteins.";
RL   Cell 131:887-900(2007).
RN   [14]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=18077395; DOI=10.1073/pnas.0710061104;
RA   Wang B., Elledge S.J.;
RT   "Ubc13/Rnf8 ubiquitin ligases control foci formation of the
RT   Rap80/Abraxas/Brca1/Brcc36 complex in response to DNA damage.";
RL   Proc. Natl. Acad. Sci. U.S.A. 104:20759-20763(2007).
RN   [15]
RP   FUNCTION, AND INTERACTION WITH MDC1.
RX   PubMed=18006705; DOI=10.1126/science.1150034;
RA   Kolas N.K., Chapman J.R., Nakada S., Ylanko J., Chahwan R.,
RA   Sweeney F.D., Panier S., Mendez M., Wildenhain J., Thomson T.M.,
RA   Pelletier L., Jackson S.P., Durocher D.;
RT   "Orchestration of the DNA-damage response by the RNF8 ubiquitin
RT   ligase.";
RL   Science 318:1637-1640(2007).
RN   [16]
RP   FUNCTION, AND DEVELOPMENTAL STAGE.
RX   PubMed=17724460; DOI=10.1038/sj.onc.1210782;
RA   Plans V., Guerra-Rebollo M., Thomson T.M.;
RT   "Regulation of mitotic exit by the RNF8 ubiquitin ligase.";
RL   Oncogene 27:1355-1365(2008).
RN   [17]
RP   FUNCTION.
RX   PubMed=18948756; DOI=10.4161/cc.7.21.6949;
RA   Zhang S., Chea J., Meng X., Zhou Y., Lee E.Y.C., Lee M.Y.W.T.;
RT   "PCNA is ubiquitinated by RNF8.";
RL   Cell Cycle 7:3399-3404(2008).
RN   [18]
RP   FUNCTION.
RX   PubMed=18337245; DOI=10.1074/jbc.M710197200;
RA   Sakasai R., Tibbetts R.;
RT   "RNF8-dependent and RNF8-independent regulation of 53BP1 in response
RT   to DNA damage.";
RL   J. Biol. Chem. 283:13549-13555(2008).
RN   [19]
RP   INTERACTION WITH UBE2N.
RX   PubMed=18678647; DOI=10.1128/MCB.00987-08;
RA   Huen M.S.Y., Huang J., Yuan J., Yamamoto M., Akira S., Ashley C.,
RA   Xiao W., Chen J.;
RT   "Noncanonical E2 variant-independent function of UBC13 in promoting
RT   checkpoint protein assembly.";
RL   Mol. Cell. Biol. 28:6104-6112(2008).
RN   [20]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [21]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [22]
RP   INTERACTION WITH HERC2.
RX   PubMed=20023648; DOI=10.1038/ncb2008;
RA   Bekker-Jensen S., Rendtlew Danielsen J., Fugger K., Gromova I.,
RA   Nerstedt A., Lukas C., Bartek J., Lukas J., Mailand N.;
RT   "HERC2 coordinates ubiquitin-dependent assembly of DNA repair factors
RT   on damaged chromosomes.";
RL   Nat. Cell Biol. 12:80-86(2010).
RN   [23]
RP   FUNCTION.
RX   PubMed=19203578; DOI=10.1016/j.cell.2008.12.042;
RA   Stewart G.S., Panier S., Townsend K., Al-Hakim A.K., Kolas N.K.,
RA   Miller E.S., Nakada S., Ylanko J., Olivarius S., Mendez M.,
RA   Oldreive C., Wildenhain J., Tagliaferro A., Pelletier L.,
RA   Taubenheim N., Durandy A., Byrd P.J., Stankovic T., Taylor A.M.R.,
RA   Durocher D.;
RT   "The RIDDLE syndrome protein mediates a ubiquitin-dependent signaling
RT   cascade at sites of DNA damage.";
RL   Cell 136:420-434(2009).
RN   [24]
RP   FUNCTION.
RX   PubMed=19203579; DOI=10.1016/j.cell.2008.12.041;
RA   Doil C., Mailand N., Bekker-Jensen S., Menard P., Larsen D.H.,
RA   Pepperkok R., Ellenberg J., Panier S., Durocher D., Bartek J.,
RA   Lukas J., Lukas C.;
RT   "RNF168 binds and amplifies ubiquitin conjugates on damaged
RT   chromosomes to allow accumulation of repair proteins.";
RL   Cell 136:435-446(2009).
RN   [25]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=19124460; DOI=10.1074/jbc.M809158200;
RA   Gong Z., Cho Y.-W., Kim J.-E., Ge K., Chen J.;
RT   "Accumulation of Pax2 transactivation domain interaction protein
RT   (PTIP) at sites of DNA breaks via RNF8-dependent pathway is required
RT   for cell survival after DNA damage.";
RL   J. Biol. Chem. 284:7284-7293(2009).
RN   [26]
RP   FUNCTION.
RX   PubMed=19015238; DOI=10.1128/MCB.01302-08;
RA   Wu J., Huen M.S.Y., Lu L.-Y., Ye L., Dou Y., Ljungman M., Chen J.,
RA   Yu X.;
RT   "Histone ubiquitination associates with BRCA1-dependent DNA damage
RT   response.";
RL   Mol. Cell. Biol. 29:849-860(2009).
RN   [27]
RP   FUNCTION.
RX   PubMed=19202061; DOI=10.1073/pnas.0807485106;
RA   Shao G., Lilli D.R., Patterson-Fortin J., Coleman K.A.,
RA   Morrissey D.E., Greenberg R.A.;
RT   "The Rap80-BRCC36 de-ubiquitinating enzyme complex antagonizes RNF8-
RT   Ubc13-dependent ubiquitination events at DNA double strand breaks.";
RL   Proc. Natl. Acad. Sci. U.S.A. 106:3166-3171(2009).
RN   [28]
RP   FUNCTION.
RX   PubMed=20550933; DOI=10.1016/j.cell.2010.04.038;
RA   Shanbhag N.M., Rafalska-Metcalf I.U., Balane-Bolivar C., Janicki S.M.,
RA   Greenberg R.A.;
RT   "ATM-dependent chromatin changes silence transcription in cis to DNA
RT   double-strand breaks.";
RL   Cell 141:970-981(2010).
RN   [29]
RP   FUNCTION.
RX   PubMed=21558560; DOI=10.1074/jbc.M111.232041;
RA   Sy S.M., Jiang J., Dong S.S., Lok G.T., Wu J., Cai H., Yeung E.S.,
RA   Huang J., Chen J., Deng Y., Huen M.S.;
RT   "Critical roles of ring finger protein RNF8 in replication stress
RT   responses.";
RL   J. Biol. Chem. 286:22355-22361(2011).
RN   [30]
RP   FUNCTION, AND MUTAGENESIS OF ARG-42 AND CYS-406.
RX   PubMed=21857671; DOI=10.1038/ncb2326;
RA   Peuscher M.H., Jacobs J.J.;
RT   "DNA-damage response and repair activities at uncapped telomeres
RT   depend on RNF8.";
RL   Nat. Cell Biol. 13:1139-1145(2011).
RN   [31]
RP   FUNCTION.
RX   PubMed=22865450; DOI=10.1158/0008-5472.CAN-12-1057;
RA   Nakada S., Yonamine R.M., Matsuo K.;
RT   "RNF8 regulates assembly of RAD51 at DNA double-strand breaks in the
RT   absence of BRCA1 and 53BP1.";
RL   Cancer Res. 72:4974-4983(2012).
RN   [32]
RP   FUNCTION IN UBIQUITINATION OF KDM4A, AND MUTAGENESIS OF ILE-405.
RX   PubMed=22373579; DOI=10.1038/emboj.2012.47;
RA   Mallette F.A., Mattiroli F., Cui G., Young L.C., Hendzel M.J., Mer G.,
RA   Sixma T.K., Richard S.;
RT   "RNF8- and RNF168-dependent degradation of KDM4A/JMJD2A triggers 53BP1
RT   recruitment to DNA damage sites.";
RL   EMBO J. 31:1865-1878(2012).
RN   [33]
RP   FUNCTION.
RX   PubMed=22531782; DOI=10.1038/emboj.2012.104;
RA   Luijsterburg M.S., Acs K., Ackermann L., Wiegant W.W.,
RA   Bekker-Jensen S., Larsen D.H., Khanna K.K., van Attikum H.,
RA   Mailand N., Dantuma N.P.;
RT   "A new non-catalytic role for ubiquitin ligase RNF8 in unfolding
RT   higher-order chromatin structure.";
RL   EMBO J. 31:2511-2527(2012).
RN   [34]
RP   INTERACTION WITH HUMAN HERPESVIRUS 1 ICP0, AND MUTAGENESIS OF ARG-42.
RX   PubMed=22405594; DOI=10.1016/j.molcel.2012.02.004;
RA   Chaurushiya M.S., Lilley C.E., Aslanian A., Meisenhelder J.,
RA   Scott D.C., Landry S., Ticau S., Boutell C., Yates J.R. III,
RA   Schulman B.A., Hunter T., Weitzman M.D.;
RT   "Viral E3 ubiquitin ligase-mediated degradation of a cellular E3:
RT   viral mimicry of a cellular phosphorylation mark targets the RNF8 FHA
RT   domain.";
RL   Mol. Cell 46:79-90(2012).
RN   [35]
RP   FUNCTION.
RX   PubMed=22705371; DOI=10.1016/j.molcel.2012.05.026;
RA   Yan Z., Guo R., Paramasivam M., Shen W., Ling C., Fox D. III, Wang Y.,
RA   Oostra A.B., Kuehl J., Lee D.Y., Takata M., Hoatlin M.E.,
RA   Schindler D., Joenje H., de Winter J.P., Li L., Seidman M.M., Wang W.;
RT   "A ubiquitin-binding protein, FAAP20, links RNF8-mediated
RT   ubiquitination to the Fanconi anemia DNA repair network.";
RL   Mol. Cell 47:61-75(2012).
RN   [36]
RP   FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH UBE2N.
RX   PubMed=22266820; DOI=10.1038/nsmb.2211;
RA   Feng L., Chen J.;
RT   "The E3 ligase RNF8 regulates KU80 removal and NHEJ repair.";
RL   Nat. Struct. Mol. Biol. 19:201-206(2012).
RN   [37]
RP   FUNCTION, AND MUTAGENESIS OF ILE-405.
RX   PubMed=21911360; DOI=10.1093/nar/gkr655;
RA   Lok G.T., Sy S.M., Dong S.S., Ching Y.P., Tsao S.W., Thomson T.M.,
RA   Huen M.S.;
RT   "Differential regulation of RNF8-mediated Lys48- and Lys63-based poly-
RT   ubiquitylation.";
RL   Nucleic Acids Res. 40:196-205(2012).
RN   [38]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-157, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [39]
RP   STRUCTURE BY NMR OF 8-139.
RG   RIKEN structural genomics initiative (RSGI);
RT   "Solution structure of the FHA domain of human ubiquitin ligase
RT   protein RNF8.";
RL   Submitted (NOV-2005) to the PDB data bank.
RN   [40]
RP   X-RAY CRYSTALLOGRAPHY (1.35 ANGSTROMS) OF 13-146 IN COMPLEX WITH
RP   PHOSPHOPEPTIDE, FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR
RP   LOCATION.
RX   PubMed=18001825; DOI=10.1016/j.cell.2007.09.041;
RA   Huen M.S.Y., Grant R., Manke I., Minn K., Yu X., Yaffe M.B., Chen J.;
RT   "RNF8 transduces the DNA-damage signal via histone ubiquitylation and
RT   checkpoint protein assembly.";
RL   Cell 131:901-914(2007).
RN   [41]
RP   X-RAY CRYSTALLOGRAPHY (1.9 ANGSTROMS) OF 351-483 IN COMPLEX WITH ZINC,
RP   SUBUNIT, FUNCTION, AND MUTAGENESIS OF ASP-443.
RX   PubMed=22980979; DOI=10.1016/j.cell.2012.08.005;
RA   Mattiroli F., Vissers J.H., van Dijk W.J., Ikpa P., Citterio E.,
RA   Vermeulen W., Marteijn J.A., Sixma T.K.;
RT   "RNF168 ubiquitinates K13-15 on H2A/H2AX to drive DNA Damage
RT   signaling.";
RL   Cell 150:1182-1195(2012).
RN   [42]
RP   X-RAY CRYSTALLOGRAPHY (4.8 ANGSTROMS) OF 345-485 IN COMPLEX WITH
RP   UBE2N, AND MUTAGENESIS OF ILE-405.
RX   PubMed=22589545; DOI=10.1074/jbc.M112.359653;
RA   Campbell S.J., Edwards R.A., Leung C.C., Neculai D., Hodge C.D.,
RA   Dhe-Paganon S., Glover J.N.;
RT   "Molecular insights into the function of RING Finger (RNF)-containing
RT   proteins hRNF8 and hRNF168 in Ubc13/Mms2-dependent ubiquitylation.";
RL   J. Biol. Chem. 287:23900-23910(2012).
CC   -!- FUNCTION: E3 ubiquitin-protein ligase that plays a key role in DNA
CC       damage signaling via 2 distinct roles: by mediating the 'Lys-63'-
CC       linked ubiquitination of histones H2A and H2AX and promoting the
CC       recruitment of DNA repair proteins at double-strand breaks (DSBs)
CC       sites, and by catalyzing 'Lys-48'-linked ubiquitination to remove
CC       target proteins from DNA damage sites. Following DNA DSBs, it is
CC       recruited to the sites of damage by ATM-phosphorylated MDC1 and
CC       catalyzes the 'Lys-63'-linked ubiquitination of histones H2A and
CC       H2AX, thereby promoting the formation of TP53BP1 and BRCA1
CC       ionizing radiation-induced foci (IRIF). Also controls the
CC       recruitment of UIMC1-BRCC3 (RAP80-BRCC36) and PAXIP1/PTIP to DNA
CC       damage sites. Also recruited at DNA interstrand cross-links (ICLs)
CC       sites and catalyzes 'Lys-63'-linked ubiquitination of histones H2A
CC       and H2AX, leading to recruitment of FAAP20/C1orf86 and Fanconi
CC       anemia (FA) complex, followed by interstrand cross-link repair.
CC       H2A ubiquitination also mediates the ATM-dependent transcriptional
CC       silencing at regions flanking DSBs in cis, a mechanism to avoid
CC       collision between transcription and repair intermediates. Promotes
CC       the formation of 'Lys-63'-linked polyubiquitin chains via
CC       interactions with the specific ubiquitin-conjugating UBE2N/UBC13
CC       and ubiquitinates non-histone substrates such as PCNA. Substrates
CC       that are polyubiquitinated at 'Lys-63' are usually not targeted
CC       for degradation. Also catalyzes the formation of 'Lys-48'-linked
CC       polyubiquitin chains via interaction with the ubiquitin-
CC       conjugating UBE2L6/UBCH8, leading to degradation of substrate
CC       proteins such as CHEK2, JMJD2A/KDM4A and KU80/XRCC5: it is still
CC       unclear how the preference toward 'Lys-48'- versus 'Lys-63'-linked
CC       ubiquitination is regulated but it could be due to RNF8 ability to
CC       interact with specific E2 specific ligases. For instance,
CC       interaction with phosphorylated HERC2 promotes the association
CC       between RNF8 and UBE2N/UBC13 and favors the specific formation of
CC       'Lys-63'-linked ubiquitin chains. Promotes non-homologous end
CC       joining (NHEJ) by promoting the 'Lys-48'-linked ubiquitination and
CC       degradation the of KU80/XRCC5. Following DNA damage, mediates the
CC       ubiquitination and degradation of JMJD2A/KDM4A in collaboration
CC       with RNF168, leading to unmask H4K20me2 mark and promote the
CC       recruitment of TP53BP1 at DNA damage sites (PubMed:11322894,
CC       PubMed:14981089, PubMed:17724460, PubMed:18001824,
CC       PubMed:18001825, PubMed:18006705, PubMed:18077395,
CC       PubMed:18337245, PubMed:18948756, PubMed:19015238,
CC       PubMed:19124460, PubMed:19202061, PubMed:19203578,
CC       PubMed:19203579, PubMed:20550933, PubMed:21558560,
CC       PubMed:21857671, PubMed:21911360, PubMed:22266820,
CC       PubMed:22373579, PubMed:22531782, PubMed:22705371,
CC       PubMed:22865450, PubMed:22980979). Following DNA damage, mediates
CC       the ubiquitination and degradation of POLD4/p12, a subunit of DNA
CC       polymerase delta. In the absence of POLD4, DNA polymerase delta
CC       complex exhibits higher proofreading activity (PubMed:23233665).
CC       In addition to its function in damage signaling, also plays a role
CC       in higher-order chromatin structure by mediating extensive
CC       chromatin decondensation. Involved in the activation of ATM by
CC       promoting histone H2B ubiquitination, which indirectly triggers
CC       histone H4 'Lys-16' acetylation (H4K16ac), establishing a
CC       chromatin environment that promotes efficient activation of ATM
CC       kinase. Required in the testis, where it plays a role in the
CC       replacement of histones during spermatogenesis. At uncapped
CC       telomeres, promotes the joining of deprotected chromosome ends by
CC       inducing H2A ubiquitination and TP53BP1 recruitment, suggesting
CC       that it may enhance cancer development by aggravating telomere-
CC       induced genome instability in case of telomeric crisis. Promotes
CC       the assembly of RAD51 at DNA DSBs in the absence of BRCA1 and
CC       TP53BP1 Also involved in class switch recombination in immune
CC       system, via its role in regulation of DSBs repair. May be required
CC       for proper exit from mitosis after spindle checkpoint activation
CC       and may regulate cytokinesis. May play a role in the regulation of
CC       RXRA-mediated transcriptional activity. Not involved in RXRA
CC       ubiquitination by UBE2E2 (PubMed:11322894, PubMed:14981089,
CC       PubMed:17724460, PubMed:18001824, PubMed:18001825,
CC       PubMed:18006705, PubMed:18077395, PubMed:18337245,
CC       PubMed:18948756, PubMed:19015238, PubMed:19124460,
CC       PubMed:19202061, PubMed:19203578, PubMed:19203579,
CC       PubMed:20550933, PubMed:21558560, PubMed:21857671,
CC       PubMed:21911360, PubMed:22266820, PubMed:22373579,
CC       PubMed:22531782, PubMed:22705371, PubMed:22865450,
CC       PubMed:22980979). {ECO:0000269|PubMed:11322894,
CC       ECO:0000269|PubMed:14981089, ECO:0000269|PubMed:17724460,
CC       ECO:0000269|PubMed:18001824, ECO:0000269|PubMed:18001825,
CC       ECO:0000269|PubMed:18006705, ECO:0000269|PubMed:18077395,
CC       ECO:0000269|PubMed:18337245, ECO:0000269|PubMed:18948756,
CC       ECO:0000269|PubMed:19015238, ECO:0000269|PubMed:19124460,
CC       ECO:0000269|PubMed:19202061, ECO:0000269|PubMed:19203578,
CC       ECO:0000269|PubMed:19203579, ECO:0000269|PubMed:20550933,
CC       ECO:0000269|PubMed:21558560, ECO:0000269|PubMed:21857671,
CC       ECO:0000269|PubMed:21911360, ECO:0000269|PubMed:22266820,
CC       ECO:0000269|PubMed:22373579, ECO:0000269|PubMed:22531782,
CC       ECO:0000269|PubMed:22705371, ECO:0000269|PubMed:22865450,
CC       ECO:0000269|PubMed:22980979, ECO:0000269|PubMed:23233665}.
CC   -!- CATALYTIC ACTIVITY: S-ubiquitinyl-[E2 ubiquitin-conjugating
CC       enzyme]-L-cysteine + [acceptor protein]-L-lysine = [E2 ubiquitin-
CC       conjugating enzyme]-L-cysteine + N(6)-ubiquitinyl-[acceptor
CC       protein]-L-lysine. {ECO:0000255|HAMAP-Rule:MF_03067}.
CC   -!- PATHWAY: Protein modification; protein ubiquitination.
CC       {ECO:0000255|HAMAP-Rule:MF_03067}.
CC   -!- SUBUNIT: Homodimer. Forms a E2-E3 ubiquitin ligase complex
CC       composed of the RNF8 homodimer and a E2 heterodimer of UBE2N and
CC       UBE2V2. Interacts with class III E2s, including UBE2E1, UBE2E2,
CC       and UBE2E3 and with UBE2N. Interacts with RXRA. Interacts (via FHA
CC       domain) with ATM-phosphorylated MDC1. Interacts (via FHA domain)
CC       with 'Thr-4827' phosphorylated HERC2 (via C-terminus). Interacts
CC       (via FHA domain) with phosphorylated human herpesvirus 1 ICP0
CC       protein; leading to RNF8 degradation by the proteasome.
CC       {ECO:0000269|PubMed:11322894, ECO:0000269|PubMed:14981089,
CC       ECO:0000269|PubMed:16215985, ECO:0000269|PubMed:18001824,
CC       ECO:0000269|PubMed:18001825, ECO:0000269|PubMed:18006705,
CC       ECO:0000269|PubMed:18678647, ECO:0000269|PubMed:20023648,
CC       ECO:0000269|PubMed:22266820, ECO:0000269|PubMed:22405594,
CC       ECO:0000269|PubMed:22589545, ECO:0000269|PubMed:22980979}.
CC   -!- INTERACTION:
CC       Self; NbExp=3; IntAct=EBI-373337, EBI-373337;
CC       Q9C0F1:CEP44; NbExp=3; IntAct=EBI-373337, EBI-744115;
CC       V9HW80:HEL-S-70; NbExp=3; IntAct=EBI-373337, EBI-10175326;
CC       Q8IX15-3:HOMEZ; NbExp=3; IntAct=EBI-373337, EBI-10172004;
CC       Q9Y6D9:MAD1L1; NbExp=5; IntAct=EBI-373337, EBI-742610;
CC       Q14676:MDC1; NbExp=11; IntAct=EBI-373337, EBI-495644;
CC       Q9UL42:PNMA2; NbExp=6; IntAct=EBI-373337, EBI-302355;
CC       O43251:RBFOX2; NbExp=3; IntAct=EBI-373337, EBI-746056;
CC       Q9UH03:SEPT3; NbExp=5; IntAct=EBI-373337, EBI-727037;
CC       O75558:STX11; NbExp=4; IntAct=EBI-373337, EBI-714135;
CC       Q9BSE2:TMEM79; NbExp=5; IntAct=EBI-373337, EBI-8649725;
CC       Q99986:VRK1; NbExp=2; IntAct=EBI-373337, EBI-1769146;
CC       O00401:WASL; NbExp=6; IntAct=EBI-373337, EBI-957615;
CC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000255|HAMAP-Rule:MF_03067,
CC       ECO:0000269|PubMed:11322894, ECO:0000269|PubMed:14981089,
CC       ECO:0000269|PubMed:16215985, ECO:0000269|PubMed:23233665}. Midbody
CC       {ECO:0000255|HAMAP-Rule:MF_03067}. Chromosome, telomere
CC       {ECO:0000255|HAMAP-Rule:MF_03067}. Note=Recruited at uncapped
CC       telomeres (By similarity). Following DNA damage, such as double-
CC       strand breaks, recruited to the sites of damage (PubMed:18001824,
CC       PubMed:18077395, PubMed:22266820, PubMed:23233665). During
CC       prophase, concomitant with nuclear envelope breakdown, localizes
CC       throughout the cell, with a dotted pattern. In telophase, again in
CC       the nucleus and also with a discrete dotted pattern in the
CC       cytoplasm. In late telophase and during cytokinesis, localizes in
CC       the midbody of the tubulin bridge joining the daughter cells. Does
CC       not seem to be associated with condensed chromosomes at any time
CC       during the cell cycle. {ECO:0000255|HAMAP-Rule:MF_03067,
CC       ECO:0000269|PubMed:18001824, ECO:0000269|PubMed:18077395,
CC       ECO:0000269|PubMed:22266820, ECO:0000269|PubMed:23233665}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=O76064-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=O76064-2; Sequence=VSP_036671, VSP_037831;
CC         Note=May be produced at very low levels due to a premature stop
CC         codon in the mRNA, leading to nonsense-mediated mRNA decay. No
CC         experimental confirmation available.;
CC       Name=3;
CC         IsoId=O76064-3; Sequence=VSP_054037, VSP_054038;
CC         Note=No experimental confirmation available. Gene prediction
CC         based on EST data.;
CC   -!- TISSUE SPECIFICITY: Ubiquitous. In fetal tissues, highest
CC       expression in brain, thymus and liver. In adult tissues, highest
CC       levels in brain and testis, lowest levels in peripheral blood
CC       cells. {ECO:0000269|PubMed:16215985, ECO:0000269|PubMed:9852682}.
CC   -!- DEVELOPMENTAL STAGE: Low levels at the G1-S boundary increase in
CC       intensity during S phase and until the end of the G2 phase.
CC       Abruptly decreases in late mitosis (at protein level). Barely
CC       detectable in anaphase. {ECO:0000269|PubMed:17724460}.
CC   -!- DOMAIN: The FHA domain specifically recognizes and binds ATM-
CC       phosphorylated MDC1 and 'Thr-4827' phosphorylated HERC2
CC       (PubMed:18001824). This domain is required for proper recruitment
CC       to DNA damage sites after UV irradiation, ionizing radiation, or
CC       treatment with an alkylating agent (PubMed:23233665).
CC       {ECO:0000269|PubMed:18001824, ECO:0000269|PubMed:23233665}.
CC   -!- PTM: Autoubiquitinated through 'Lys-48' and 'Lys-63' of ubiquitin.
CC       'Lys-63' polyubiquitination is mediated by UBE2N. 'Lys-29'-type
CC       polyubiquitination is also observed, but it doesn't require its
CC       own functional RING-type zinc finger. {ECO:0000255|HAMAP-
CC       Rule:MF_03067, ECO:0000269|PubMed:16215985}.
CC   -!- SIMILARITY: Belongs to the RNF8 family. {ECO:0000255|HAMAP-
CC       Rule:MF_03067}.
CC   -!- CAUTION: According to a well-established model, RNF8 initiate H2A
CC       'Lys-63'-linked ubiquitination leading to recruitment of RNF168 to
CC       amplify H2A 'Lys-63'-linked ubiquitination (PubMed:19203578 and
CC       PubMed:19203579). However, other data suggest that RNF168 is the
CC       priming ubiquitin ligase by mediating monoubiquitination of 'Lys-
CC       13' and 'Lys-15' of nucleosomal histone H2A (H2AK13Ub and H2AK15Ub
CC       respectively) (PubMed:22980979). These data suggest that RNF168
CC       might be recruited to DSBs sites in a RNF8-dependent manner by
CC       binding to non-histone proteins ubiquitinated via 'Lys-63'-linked
CC       and initiates monoubiquitination of H2A, which is then amplified
CC       by RNF8 (PubMed:22980979). Additional evidences are however
CC       required to confirm these data. {ECO:0000255|HAMAP-Rule:MF_03067,
CC       ECO:0000305|PubMed:22980979}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=BAA31621.2; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG60572.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC       Sequence=EAX03945.1; Type=Erroneous gene model prediction; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AB012770; BAA33557.1; -; Genomic_DNA.
DR   EMBL; AF334675; AAQ14887.1; -; mRNA.
DR   EMBL; AB014546; BAA31621.2; ALT_INIT; mRNA.
DR   EMBL; AK298319; BAG60572.1; ALT_SEQ; mRNA.
DR   EMBL; BT007446; AAP36114.1; -; mRNA.
DR   EMBL; AK222765; BAD96485.1; -; mRNA.
DR   EMBL; AL096712; CAB75689.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03944.1; -; Genomic_DNA.
DR   EMBL; CH471081; EAX03945.1; ALT_SEQ; Genomic_DNA.
DR   EMBL; BC007517; AAH07517.1; -; mRNA.
DR   CCDS; CCDS4833.1; -. [O76064-3]
DR   CCDS; CCDS4834.1; -. [O76064-1]
DR   RefSeq; NP_003949.1; NM_003958.3. [O76064-1]
DR   RefSeq; NP_898901.1; NM_183078.2. [O76064-3]
DR   UniGene; Hs.485278; -.
DR   PDB; 2CSW; NMR; -; A=8-139.
DR   PDB; 2PIE; X-ray; 1.35 A; A=13-146.
DR   PDB; 4AYC; X-ray; 1.90 A; A/B=351-485.
DR   PDB; 4ORH; X-ray; 4.80 A; C/G/H/K/L=345-485.
DR   PDB; 4WHV; X-ray; 8.30 A; C/D/I/J=345-485.
DR   PDBsum; 2CSW; -.
DR   PDBsum; 2PIE; -.
DR   PDBsum; 4AYC; -.
DR   PDBsum; 4ORH; -.
DR   PDBsum; 4WHV; -.
DR   ProteinModelPortal; O76064; -.
DR   SMR; O76064; -.
DR   BioGrid; 114492; 55.
DR   DIP; DIP-31265N; -.
DR   IntAct; O76064; 51.
DR   MINT; MINT-1459889; -.
DR   STRING; 9606.ENSP00000362578; -.
DR   iPTMnet; O76064; -.
DR   PhosphoSitePlus; O76064; -.
DR   BioMuta; RNF8; -.
DR   EPD; O76064; -.
DR   MaxQB; O76064; -.
DR   PaxDb; O76064; -.
DR   PeptideAtlas; O76064; -.
DR   PRIDE; O76064; -.
DR   DNASU; 9025; -.
DR   Ensembl; ENST00000229866; ENSP00000229866; ENSG00000112130. [O76064-2]
DR   Ensembl; ENST00000373479; ENSP00000362578; ENSG00000112130. [O76064-1]
DR   Ensembl; ENST00000469731; ENSP00000418879; ENSG00000112130. [O76064-3]
DR   GeneID; 9025; -.
DR   KEGG; hsa:9025; -.
DR   UCSC; uc003onq.4; human. [O76064-1]
DR   CTD; 9025; -.
DR   DisGeNET; 9025; -.
DR   GeneCards; RNF8; -.
DR   HGNC; HGNC:10071; RNF8.
DR   HPA; HPA050731; -.
DR   HPA; HPA064925; -.
DR   MIM; 611685; gene.
DR   neXtProt; NX_O76064; -.
DR   OpenTargets; ENSG00000112130; -.
DR   PharmGKB; PA34445; -.
DR   eggNOG; ENOG410INBI; Eukaryota.
DR   eggNOG; ENOG410Z9IW; LUCA.
DR   GeneTree; ENSGT00400000022349; -.
DR   HOGENOM; HOG000154169; -.
DR   HOVERGEN; HBG023954; -.
DR   InParanoid; O76064; -.
DR   KO; K10667; -.
DR   OMA; IHKGDHI; -.
DR   OrthoDB; EOG091G0I40; -.
DR   PhylomeDB; O76064; -.
DR   TreeFam; TF330957; -.
DR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated phosphorylation of repair and signaling proteins at DNA double strand breaks.
DR   Reactome; R-HSA-5693571; Nonhomologous End-Joining (NHEJ).
DR   Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.
DR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.
DR   SIGNOR; O76064; -.
DR   UniPathway; UPA00143; -.
DR   ChiTaRS; RNF8; human.
DR   EvolutionaryTrace; O76064; -.
DR   GeneWiki; RNF8; -.
DR   GenomeRNAi; 9025; -.
DR   PRO; PR:O76064; -.
DR   Proteomes; UP000005640; Chromosome 6.
DR   Bgee; ENSG00000112130; -.
DR   CleanEx; HS_RNF8; -.
DR   ExpressionAtlas; O76064; baseline and differential.
DR   Genevisible; O76064; HS.
DR   GO; GO:0000781; C:chromosome, telomeric region; ISS:UniProtKB.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0030496; C:midbody; IEA:UniProtKB-SubCell.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0005634; C:nucleus; IDA:UniProtKB.
DR   GO; GO:0035861; C:site of double-strand break; IDA:UniProtKB.
DR   GO; GO:0000151; C:ubiquitin ligase complex; IDA:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; IDA:UniProtKB.
DR   GO; GO:0042393; F:histone binding; IDA:UniProtKB.
DR   GO; GO:0042802; F:identical protein binding; IPI:IntAct.
DR   GO; GO:0042803; F:protein homodimerization activity; IDA:UniProtKB.
DR   GO; GO:0031625; F:ubiquitin protein ligase binding; IPI:UniProtKB.
DR   GO; GO:0004842; F:ubiquitin-protein transferase activity; IDA:UniProtKB.
DR   GO; GO:0008270; F:zinc ion binding; IDA:UniProtKB.
DR   GO; GO:0051301; P:cell division; IEA:UniProtKB-KW.
DR   GO; GO:0006974; P:cellular response to DNA damage stimulus; IDA:UniProtKB.
DR   GO; GO:0006302; P:double-strand break repair; IDA:UniProtKB.
DR   GO; GO:0006303; P:double-strand break repair via nonhomologous end joining; ISS:UniProtKB.
DR   GO; GO:0043486; P:histone exchange; ISS:UniProtKB.
DR   GO; GO:0070535; P:histone H2A K63-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0033522; P:histone H2A ubiquitination; IDA:UniProtKB.
DR   GO; GO:0033523; P:histone H2B ubiquitination; ISS:UniProtKB.
DR   GO; GO:0036297; P:interstrand cross-link repair; TAS:UniProtKB.
DR   GO; GO:0045190; P:isotype switching; ISS:UniProtKB.
DR   GO; GO:0007067; P:mitotic nuclear division; IEA:UniProtKB-KW.
DR   GO; GO:0034244; P:negative regulation of transcription elongation from RNA polymerase II promoter; IMP:UniProtKB.
DR   GO; GO:0045739; P:positive regulation of DNA repair; IDA:UniProtKB.
DR   GO; GO:0051865; P:protein autoubiquitination; IDA:UniProtKB.
DR   GO; GO:0070936; P:protein K48-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0070534; P:protein K63-linked ubiquitination; IDA:UniProtKB.
DR   GO; GO:0010212; P:response to ionizing radiation; IDA:UniProtKB.
DR   GO; GO:0007286; P:spermatid development; ISS:UniProtKB.
DR   GO; GO:0006511; P:ubiquitin-dependent protein catabolic process; IDA:UniProtKB.
DR   CDD; cd00162; RING; 1.
DR   Gene3D; 3.30.40.10; -; 1.
DR   HAMAP; MF_03067; RNF8; 1.
DR   InterPro; IPR000253; FHA_dom.
DR   InterPro; IPR017335; RNF8.
DR   InterPro; IPR008984; SMAD_FHA_domain.
DR   InterPro; IPR001841; Znf_RING.
DR   InterPro; IPR013083; Znf_RING/FYVE/PHD.
DR   InterPro; IPR017907; Znf_RING_CS.
DR   Pfam; PF00498; FHA; 1.
DR   PIRSF; PIRSF037950; E3_ubiquit_lig_RNF8; 1.
DR   SMART; SM00240; FHA; 1.
DR   SMART; SM00184; RING; 1.
DR   SUPFAM; SSF49879; SSF49879; 1.
DR   PROSITE; PS50006; FHA_DOMAIN; 1.
DR   PROSITE; PS00518; ZF_RING_1; 1.
DR   PROSITE; PS50089; ZF_RING_2; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Cell cycle; Cell division;
KW   Chromatin regulator; Chromosome; Complete proteome;
KW   Direct protein sequencing; DNA damage; DNA repair; Metal-binding;
KW   Mitosis; Nucleus; Phosphoprotein; Polymorphism; Reference proteome;
KW   Telomere; Transferase; Ubl conjugation; Ubl conjugation pathway; Zinc;
KW   Zinc-finger.
FT   CHAIN         1    485       E3 ubiquitin-protein ligase RNF8.
FT                                /FTId=PRO_0000056048.
FT   DOMAIN       38     92       FHA. {ECO:0000255|HAMAP-Rule:MF_03067}.
FT   ZN_FING     403    441       RING-type. {ECO:0000255|HAMAP-
FT                                Rule:MF_03067}.
FT   COMPBIAS    276    345       Gln-rich.
FT   MOD_RES     157    157       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   VAR_SEQ      81     98       SLNGVWLNRARLEPLRVY -> SFPSEKAEDFTAAGERFL
FT                                (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_036671.
FT   VAR_SEQ      99    485       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:14702039}.
FT                                /FTId=VSP_037831.
FT   VAR_SEQ     413    448       AVTLNCAHSFCSYCINEWMKRKIECPICRKDIKSKT -> Q
FT                                RDCSEDRALRAFERLPGSASLRWSGGFSLAVTPLL (in
FT                                isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054037.
FT   VAR_SEQ     449    485       Missing (in isoform 3). {ECO:0000305}.
FT                                /FTId=VSP_054038.
FT   VARIANT     162    162       A -> T (in dbSNP:rs34338974).
FT                                /FTId=VAR_052096.
FT   VARIANT     473    473       I -> V (in dbSNP:rs1139944).
FT                                /FTId=VAR_052097.
FT   MUTAGEN      42     42       R->A: Abolishes interaction with ATM-
FT                                phosphorylated MDC1. Abolishes
FT                                interaction with human herpesvirus 1
FT                                ICP0. Abolishes recruitment to DNA damage
FT                                sites after UV irradiation, ionizing
FT                                radiation, or treatment with an
FT                                alkylating agent.
FT                                {ECO:0000269|PubMed:18001824,
FT                                ECO:0000269|PubMed:21857671,
FT                                ECO:0000269|PubMed:22405594,
FT                                ECO:0000269|PubMed:23233665}.
FT   MUTAGEN     403    403       C->S: Marked reduction of E2-dependent
FT                                ubiquitination of histone H2A. Loss of
FT                                UBE2E2- and UBE2N-binding. Loss of
FT                                nuclear localization.
FT                                {ECO:0000269|PubMed:11322894,
FT                                ECO:0000269|PubMed:14981089,
FT                                ECO:0000269|PubMed:16215985,
FT                                ECO:0000269|PubMed:18001824}.
FT   MUTAGEN     405    405       I->A: Impairs interaction with
FT                                UBE2L6/UBCH8 and ability to mediate 'Lys-
FT                                48'-linked ubiquitination E3 ligase
FT                                activity, while it still catalyzes 'Lys-
FT                                63'-linked ubiquitination and still
FT                                interacts with UBE2N/UBC13.
FT                                {ECO:0000269|PubMed:21911360,
FT                                ECO:0000269|PubMed:22373579,
FT                                ECO:0000269|PubMed:22589545}.
FT   MUTAGEN     406    406       C->S: Abolishes ubiquitin-ligase
FT                                activity. {ECO:0000269|PubMed:21857671}.
FT   MUTAGEN     443    443       D->R: Does not affect the monomeric
FT                                structure but abolishes ability to
FT                                monoubiquitinate H2A in nucleosomes.
FT                                {ECO:0000269|PubMed:22980979}.
FT   CONFLICT    230    230       V -> A (in Ref. 6; BAD96485).
FT                                {ECO:0000305}.
FT   CONFLICT    334    334       K -> R (in Ref. 6; BAD96485).
FT                                {ECO:0000305}.
FT   STRAND       16     22       {ECO:0000244|PDB:2PIE}.
FT   STRAND       29     32       {ECO:0000244|PDB:2PIE}.
FT   STRAND       38     49       {ECO:0000244|PDB:2PIE}.
FT   HELIX        56     58       {ECO:0000244|PDB:2CSW}.
FT   STRAND       64     68       {ECO:0000244|PDB:2PIE}.
FT   STRAND       74     78       {ECO:0000244|PDB:2PIE}.
FT   STRAND       85     87       {ECO:0000244|PDB:2PIE}.
FT   STRAND      105    109       {ECO:0000244|PDB:2PIE}.
FT   STRAND      119    128       {ECO:0000244|PDB:2PIE}.
FT   HELIX       129    132       {ECO:0000244|PDB:2PIE}.
FT   HELIX       133    135       {ECO:0000244|PDB:2PIE}.
FT   HELIX       351    400       {ECO:0000244|PDB:4AYC}.
FT   TURN        404    406       {ECO:0000244|PDB:4AYC}.
FT   STRAND      411    416       {ECO:0000244|PDB:4AYC}.
FT   STRAND      421    423       {ECO:0000244|PDB:4AYC}.
FT   HELIX       424    430       {ECO:0000244|PDB:4AYC}.
FT   TURN        431    433       {ECO:0000244|PDB:4AYC}.
FT   TURN        438    440       {ECO:0000244|PDB:4AYC}.
FT   STRAND      447    449       {ECO:0000244|PDB:4AYC}.
FT   HELIX       451    461       {ECO:0000244|PDB:4AYC}.
FT   HELIX       466    480       {ECO:0000244|PDB:4AYC}.
SQ   SEQUENCE   485 AA;  55518 MW;  54650B2FFC9948B1 CRC64;
     MGEPGFFVTG DRAGGRSWCL RRVGMSAGWL LLEDGCEVTV GRGFGVTYQL VSKICPLMIS
     RNHCVLKQNP EGQWTIMDNK SLNGVWLNRA RLEPLRVYSI HQGDYIQLGV PLENKENAEY
     EYEVTEEDWE TIYPCLSPKN DQMIEKNKEL RTKRKFSLDE LAGPGAEGPS NLKSKINKVS
     CESGQPVKSQ GKGEVASTPS DNLDPKLTAL EPSKTTGAPI YPGFPKVTEV HHEQKASNSS
     ASQRSLQMFK VTMSRILRLK IQMQEKHEAV MNVKKQTQKG NSKKVVQMEQ ELQDLQSQLC
     AEQAQQQARV EQLEKTFQEE EQHLQGLEIA QGEKDLKQQL AQALQEHWAL MEELNRSKKD
     FEAIIQAKNK ELEQTKEEKE KMQAQKEEVL SHMNDVLENE LQCIICSEYF IEAVTLNCAH
     SFCSYCINEW MKRKIECPIC RKDIKSKTYS LVLDNCINKM VNNLSSEVKE RRIVLIRERK
     AKRLF
//
